XML 15 R33.htm IDEA: XBRL DOCUMENT v3.3.0.814

Investment in Inex Bio, Inc - Summary of Net Consideration Paid to Holdings (Detail) - Inex Bio Holdings $ in Thousands	9 Months Ended
	Sep. 30, 2015 USD ($)
Business Acquisition [Line Items]
Payments to acquire business	$ 6,518
Fair value of warrants	22,747
Less cash paid to acquire shares in Inex Bio	(1,100)
Aggregate purchase price	$ 28,165

X

- Definition

Business combination consideration transferred cash paid to acquire shares.

+ References

No definition available.

+ Details

Name:	nk_BusinessCombinationConsiderationCashPaidToAcquireShares
Namespace Prefix:	nk_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Definition

Business combination consideration transferred warrants fair value.

+ References

No definition available.

+ Details

Name:	nk_BusinessCombinationConsiderationTransferredWarrantsFairValue
Namespace Prefix:	nk_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_BusinessAcquisitionLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef



-Publisher FASB



-Name Accounting Standards Codification



-Topic 805



-SubTopic 30



-Section 30



-Paragraph 7



-URI http://asc.fasb.org/extlink&oid=6911251&loc=d3e6578-128477



Reference 2: http://www.xbrl.org/2003/role/presentationRef



-Publisher FASB



-Name Accounting Standards Codification



-Topic 805



-SubTopic 30



-Section 50



-Paragraph 1



-Subparagraph (b)



-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479



Reference 3: http://www.xbrl.org/2003/role/presentationRef



-Publisher FASB



-Name Accounting Standards Codification



-Topic 805



-SubTopic 30



-Section 30



-Paragraph 8



-URI http://asc.fasb.org/extlink&oid=6911251&loc=d3e6613-128477

+ Details

Name:	us-gaap_BusinessCombinationConsiderationTransferred1
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Definition

The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef



-Publisher FASB



-Name Accounting Standards Codification



-Glossary Investing Activities



-URI http://asc.fasb.org/extlink&oid=6516133



Reference 2: http://www.xbrl.org/2003/role/presentationRef



-Publisher FASB



-Name Accounting Standards Codification



-Topic 230



-SubTopic 10



-Section 45



-Paragraph 13



-Subparagraph (b)



-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3213-108585

+ Details

Name:	us-gaap_PaymentsToAcquireBusinessesGross
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Details

Name:	us-gaap_BusinessAcquisitionAxis=nk_InexBioHoldingsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: